Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Express Scripts
Mallinckrodt
Medtronic
Moodys

Last Updated: May 24, 2022

CLINICAL TRIALS PROFILE FOR INJECTAFER


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Injectafer

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00994318 ↗ Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) Completed American Regent, Inc. Phase 3 2009-12-01 Phase IIIb study to evaluate the long-term efficacy of ferric carboxymaltose (FCM) (using targeted ferritin levels to determine dosing) or oral iron in non-dialysis-dependent chronic kidney disease (NDD-CKD) subjects with iron deficiency anaemia (IDA).
NCT00994318 ↗ Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) Completed ICON Clinical Research Phase 3 2009-12-01 Phase IIIb study to evaluate the long-term efficacy of ferric carboxymaltose (FCM) (using targeted ferritin levels to determine dosing) or oral iron in non-dialysis-dependent chronic kidney disease (NDD-CKD) subjects with iron deficiency anaemia (IDA).
NCT00994318 ↗ Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) Completed Luitpold Pharmaceuticals Phase 3 2009-12-01 Phase IIIb study to evaluate the long-term efficacy of ferric carboxymaltose (FCM) (using targeted ferritin levels to determine dosing) or oral iron in non-dialysis-dependent chronic kidney disease (NDD-CKD) subjects with iron deficiency anaemia (IDA).
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Injectafer

Condition Name

Condition Name for Injectafer
Intervention Trials
Iron Deficiency Anemia 7
Heart Failure 3
Iron Deficiency Anaemia 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Injectafer
Intervention Trials
Anemia, Iron-Deficiency 18
Anemia 13
Deficiency Diseases 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Injectafer

Trials by Country

Trials by Country for Injectafer
Location Trials
United States 104
Canada 8
Australia 7
Poland 4
Spain 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Injectafer
Location Trials
Texas 7
Florida 7
Pennsylvania 6
New York 5
North Carolina 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Injectafer

Clinical Trial Phase

Clinical Trial Phase for Injectafer
Clinical Trial Phase Trials
Phase 4 4
Phase 3 8
Phase 2 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Injectafer
Clinical Trial Phase Trials
Completed 14
Recruiting 3
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Injectafer

Sponsor Name

Sponsor Name for Injectafer
Sponsor Trials
American Regent, Inc. 13
Luitpold Pharmaceuticals 12
Pharmacosmos A/S 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Injectafer
Sponsor Trials
Industry 34
Other 9
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
AstraZeneca
Mallinckrodt
Harvard Business School
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.